Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cytokine|September 14, 2018
IFNG +874 A/T is associated with acute lymphoblastic leukemia in Mexican MestizosBetsy Annel González-Quezada, Hilario Flores-Aguilar, Alberto Olaya-Vargas, et al.
BMC Cancer|October 31, 2014
Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance programRoberto Rivera-Luna, Jaime Shalkow-Klincovstein, Liliana Velasco-Hidalgo, et al.
Immunologic Research|December 22, 2014
Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1)Marco Yamazaki-Nakashimada, José L Maravillas-Montero, Laura Berrón-Ruiz, et al.
Scientific Reports|March 8, 2022
Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancerSergio Enríquez-Flores, Luis A Flores-López, Ignacio De la Mora-De la Mora, et al.
Biomolecules|October 26, 2024
Selective Inhibition of Deamidated Triosephosphate Isomerase by Disulfiram, Curcumin, and Sodium Dichloroacetate: Synergistic Therapeutic Strategies for T-Cell Acute Lymphoblastic Leukemia in Jurkat CellsLuis A Flores-López, Ignacio De la Mora-De la Mora, Claudia M Malagón-Reyes, et al.
Hematology (Amsterdam, Netherlands)|December 24, 2014
Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in MéxicoLaura Rodríguez, Óscar González-Llano, Laura Villarreal, et al.
Journal of Global Oncology|August 8, 2018
Delivery of Pediatric Cancer Care in Mexico: A National SurveyLaura Rodriguez-Romo, Alberto Olaya Vargas, Sumit Gupta, et al.
The Biochemical Journal|February 2, 2026
Post-translational modifications of triosephosphate isomerase reveal metabolic vulnerabilities in T-ALL. Effect of combining dichloroacetic acid and the PPI rabeprazoleYoalli Martínez-Pérez, Ignacio De la Mora-De la Mora, Gloria Hernández-Alcántara, et al.
Frontiers in Oncology|December 1, 2025
Blinatumomab-induced remission followed by haploidentical transplantation in pediatric relapsed/refractory pre-B ALL: a multicenter study in MexicoAlberto Olaya-Vargas, Haydee Salazar-Rosales, Yadira Melchor-Vidal, et al.
Frontiers in Oncology|July 3, 2025
High-risk neuroblastoma in Mexico: from multimodal treatment to immunotherapy. Regarding the first case treated with naxitamabAlberto Olaya Vargas, Haydee Salazar-Rosales, Marcela Caballero-Palacios, et al.
Pageof 4